July 27, 2017 / 11:23 AM / in 4 months

BRIEF-Valeant announces U.S. launch of siliq injection

July 27 (Reuters) - Astrazeneca Plc:

* Valeant announces U.S. launch of siliq (brodalumab) injection

* Valeant says that its dermatology unit will be renamed Ortho Dermatologics, effective immediately

* Valeant says under new senior leadership team lead by Bill Humphries, executive vice president and company group chairman, Ortho Dermatologics

* Valeant - ‍siliq has a black box warning for “risks of suicidal ideation and behavior​” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below